Jmj Impex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -67.49%
- Profit Growth 65.49%
- Ebitda 64.31%
- Net Worth -34.71%
- Total Assets -45.24%
About Jmj Impex
Jmj Impex Private Limited (JIPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 June 2010 and has a history of 14 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pushpadevi Dugar and Jhumar Dugar serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51109GJ2010PTC060960
- Company No.
060960
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Jmj Impex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushpadevi Dugar  | Director | 03-Jun-2010 | Current |
| Jhumar Dugar | Director | 03-Jun-2010 | Current |
Financial Performance of Jmj Impex.
Jmj Impex Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 67.49% decrease. The company also saw a substantial improvement in profitability, with a 65.49% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jmj Impex?
Unlock access to Jmj Impex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rishabh Biotech Private LimitedPushpadevi Dugar and Jhumar Dugar are mutual person
Rishabh Colours Private LimitedPushpadevi Dugar and Jhumar Dugar are mutual person
- Uniglobe International Llp
Jhumar Dugar is a mutual person
- Rubi Life Sciences Private Limited
Jhumar Dugar is a mutual person
- Apex Remedies Private Limited
Jhumar Dugar is a mutual person
- Rnjd Constructions Private Limited
Jhumar Dugar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jmj Impex?
Unlock and access historical data on people associated with Jmj Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jmj Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jmj Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
